Verdict: Not Yet
Lululemon Athletica’s stock opened sharply lower after the company reset its forward outlook, with shares down 20.56% premarket to $96.73 today. The move reflects more than short-term panic - it follows a substantive downgrade to the business outlook that changes the risk profile for investors considering the name.
The direct consequences of management's revision are clear in the guidance: full-year sales were trimmed to a decline of 5% to 7%, while full-year earnings-per-share guidance was revised to a range of $9.48 to $9.73. The third-quarter outlook is weaker still, with guidance implying a 10% to 11% revenue decline. Those figures frame the stock as a speculative turnaround trade rather than a straightforward buy-the-dip opportunity.
Analysts expressed caution. UBS wrote, "We don’t believe a pullback represents a good buying opportunity." The bank added that it sees substantial EPS downside over the next twelve months, limited upside risk, and that Lululemon’s roughly 11x P/E suggests much of the bad news may already be priced in - creating a balanced upside/downside skew rather than a clear value trade.
Earnings and the demand problem
The company reported headline EPS of $2.92 for the latest quarter versus $1.82 expected. On a top-line basis, revenue of $2.42 billion missed the $2.46 billion consensus. The EPS result included a one-time benefit of $0.86 from tariff refunds, which makes the apparent beat less durable when isolating underlying operational performance.
More troubling are the demand dynamics undercutting the brand. Americas revenue was down 8%, while China growth slowed to 4%. Company commentary and the results point to product misses, softer traffic, and increased promotional activity pressuring the business. Those drivers are central to the current selloff and the guidance reset.
Valuation details
Market snapshots included in the update show:
- Share price: $96.73 premarket as of September 4, 2026 at 7:47 AM EDT
- Market capitalization: $13.83 billion as of September 4, 2026 at 7:47 AM EDT
- Forward P/E: 10.9x as of January 31, 2027
- Free cash flow yield: 9.3% as of April 30, 2026
- Model fair value: $214.79, implying 76.4% upside as of September 4, 2026 at 7:47 AM EDT
The headline takeaway is that the stock’s valuation now includes a margin of safety if earnings recover. At the same time, consensus estimates have moved lower: EPS revisions are down 19.4% over one year and revenue revisions have fallen 5.06% over the same period. A low multiple offers no guarantee of protection if earnings continue to compress.
Technicals - mixed signals
Technical indicators present a split landscape:
- Daily view - Strong Buy rating with RSI at 53.4 and near-term support around $118.35, although that level sits well above the current premarket price.
- Weekly view - Sell, RSI 41.4, MACD Sell.
- Monthly view - Strong Sell, RSI 34.3, MACD Sell.
The combined technical picture suggests short-term bounce potential is weaker than the longer-term deterioration. Monthly technical support levels are identified near $113.68 and then $107.10 based on the latest technical measures.
What would change the analysis
A more constructive investment case would require multiple signs of stabilization, including:
- Revenue declines narrowing beyond the current Q3 outlook.
- Improved product acceptance and traffic trends.
- China growth stabilizing rather than slowing further.
- Consensus estimates halting their downward trajectory.
- Price holding above the post-selloff range rather than quickly making new lows.
On the analyst front, Morgan Stanley lowered its price target to $83, while UBS set a $106 target and maintained a Neutral rating. Those adjustments underscore the market’s cautious stance and the fact that professional investors are recalibrating expectations.
Bottom line
Lululemon’s stock is materially cheaper after the guidance reset, but the company's earnings trajectory is being rewritten. For most investors, waiting for confirmation that the underlying demand problems and product execution issues have stabilized may be preferable to attempting to catch an early rebound. The upside scenario remains appealing if the firm can stop the earnings drift; the downside case continues to have fresh, tangible evidence.